CLE

Noon CLE meetings are typically held on the fourth Friday of every month (with some exceptions).

 

We also host periodic breakfast CLE roundtable discussions at a North Dallas location on important IP topics.

Contact Information

 

If you have questions about the Intellectual Property Section in general, please contact the Section Chair:

 

Robert H. Johnston III - Chair

R. Johnson Law, PLLC
1722 Routh St., Suite 900
Dallas, TX 75201
Phone: 214-396-6000
Email: rjohnston@johnstonip.com

If you have questions or comments about the Website, please contact:

 

D. Scott Hemingway

Hemingway & Hansen LLP

1700 Pacific Avenue, Suite4800

Dallas, TX 75201

Phone: 214.292.8301

Email: shemingway@hh-iplaw.com

 

For a full list of Officers and Directors click here.

U.S._Courthouse_(Sam_Hall)_in_Marshall,_TX_IMG_2333.JPG
U.S._Courthouse_(Sam_Hall)_in_Marshall,_TX_IMG_2333.JPG

press to zoom
1024px-Oscilloscope_sine_square.jpg
1024px-Oscilloscope_sine_square.jpg

By Xato (Own work) [Public domain], via Wikimedia Commons

press to zoom
Sheet music: "Beauiful Dreamer" by S
Sheet music: "Beauiful Dreamer" by S

Sheet music: "Beauiful Dreamer" by Stephen Foster

press to zoom
U.S._Courthouse_(Sam_Hall)_in_Marshall,_TX_IMG_2333.JPG
U.S._Courthouse_(Sam_Hall)_in_Marshall,_TX_IMG_2333.JPG

press to zoom
1/16

Next CLE: Sept. 30, 2021 

(Virtual Zoom, Noon)

"Arthrex, Minerva, and the Future of Patent Validity”

Speaker: Professor Saurabh Vishnubhakat, Texas A&M School of Law

 

The Supreme Court’s October Term 2020 included two significant patent law decisions.  In Arthrex v. Smith & Nephew, the Court held that the USPTO’s administrative patent judges were improperly appointed principal officers, and imposed a judicial remedy to fix the constitutional defect.  In Minerva Surgical v. Hologic, the Court substantially narrowed—but did not abolish—the ability of patent owners to block past assignors from challenging patent validity.  Professor Saurabh Vishnubhakat from Texas A&M University will summarize these decisions and discuss what they mean for patent rights going forward.